Clinical Trial Update: Liposomal-Cisplatin Analogue (L-NDDP) in Treating Patients With Malignant Pleural Mesothelioma [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating the liposomal cisplatin analogue L-NDDP in malignant pleural mesothelioma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malignant Pleural Mesothelioma

Drugs mentioned

• L-NDDP (liposomal cisplatin analogue) (liposomal cisplatin analogue)

Snippet

Sponsor: NYU Langone Health | Conditions: Malignant Mesothelioma | Phase 2 | Status: COMPLETED